Literature DB >> 7670567

Effect of glycemic control on calcium and phosphorus handling and parathyroid hormone level in patients with non-insulin-dependent diabetes mellitus.

S Nagasaka1, T Murakami, T Uchikawa, S E Ishikawa, T Saito.   

Abstract

The present study was undertaken to determine whether improvement of hyperglycemia alters calcium and phosphorus handling, parathyroid hormone (PTH) secretion and bone turnover in patients with non-insulin-dependent diabetes mellitus (NIDDM). We measured serum and urinary mineral levels, serum intact PTH and osteocalcin on admission and at discharge (38 +/- 3 days later, Means +/- SEM) in 28 patients with poorly-controlled NIDDM (63 +/- 2 years old, 13 males and 15 females). During the hospitalization period, glycemic control was markedly improved. Serum calcium levels remained unchanged, but serum phosphorus increased. Urinary calcium and phosphorus excretion decreased. Serum intact PTH decreased from mid-normal (30.0 +/- 2.2 ng/l) to low normal values (24.0 +/- 1.3 ng/l) (P < 0.01, normal values: 10-65 ng/l). Serum osteocalcin increased from 4.14 +/- 0.35 to 4.92 +/- 0.40 micrograms/l (P < 0.01, normal values: 2.5-13 micrograms/l). On admission, urinary calcium and phosphorus excretion showed a positive correlation with urinary glucose excretion. Serum calcium levels showed a negative correlation with serum intact PTH (r = -0.46, P < 0.05). Moreover, the change in serum calcium during the hospitalization was negatively correlated to the change in serum intact-PTH (r = -0.45, P < 0.05). Serum phosphorus concentrations showed a positive correlation with the renal threshold for phosphorus excretion on admission (r = 0.86, P < 0.01). These results indicate that hyperglycemia causes excess urinary calcium and phosphorus excretion in patients with NIDDM. In response to urinary calcium loss, PTH secretion is mildly stimulated. Bone formation seems to be suppressed in the hyperglycemic state in spite of increased PTH secretion.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7670567     DOI: 10.1507/endocrj.42.377

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  18 in total

Review 1.  Kidney stones diseases and glycaemic statuses: focus on the latest clinical evidences.

Authors:  Leonardo Spatola; Claudio Angelini; Salvatore Badalamenti; Silvio Maringhini; Giovanni Gambaro
Journal:  Urolithiasis       Date:  2016-12-05       Impact factor: 3.436

Review 2.  Bone, sweet bone--osteoporotic fractures in diabetes mellitus.

Authors:  Christine Hamann; Stephan Kirschner; Klaus-Peter Günther; Lorenz C Hofbauer
Journal:  Nat Rev Endocrinol       Date:  2012-01-17       Impact factor: 43.330

Review 3.  The endocrine system in diabetes mellitus.

Authors:  Hisham Alrefai; Hisham Allababidi; Shiri Levy; Joseph Levy
Journal:  Endocrine       Date:  2002-07       Impact factor: 3.633

4.  Decreased bone mineral density at the distal radius, but not at the lumbar spine or the femoral neck, in Japanese type 2 diabetic patients.

Authors:  T Majima; Y Komatsu; T Yamada; Y Koike; M Shigemoto; C Takagi; I Hatanaka; K Nakao
Journal:  Osteoporos Int       Date:  2004-11-19       Impact factor: 4.507

5.  Urinary stone in a 12-year-old adolescent with new-onset type 1 diabetes and diabetic ketoacidosis.

Authors:  Kikumi Ushijima-Fuchino; Yuko Koga; Satoko Umino; Junko Nishioka; Junichiro Araki; Shuichi Yatsuga; Yushiro Yamashita
Journal:  Clin Pediatr Endocrinol       Date:  2022-06-08

6.  Bone metabolism in male patients with type 2 diabetes.

Authors:  Lahsen Achemlal; Saida Tellal; Fouad Rkiouak; Abderrazak Nouijai; Ahmed Bezza; El Mostapha Derouiche; Driss Ghafir; Abdellah El Maghraoui
Journal:  Clin Rheumatol       Date:  2005-03-04       Impact factor: 2.980

7.  Diabetic severity and risk of kidney stone disease.

Authors:  Aviva E Weinberg; Chirag J Patel; Glenn M Chertow; John T Leppert
Journal:  Eur Urol       Date:  2013-03-17       Impact factor: 20.096

8.  The association of adiposity with parathyroid hormone in healthy older adults.

Authors:  Arpita Patel Pitroda; Susan S Harris; Bess Dawson-Hughes
Journal:  Endocrine       Date:  2009-08-27       Impact factor: 3.633

9.  Si and Ca individually and combinatorially target enhanced MC3T3-E1 subclone 4 early osteogenic marker expression.

Authors:  Venu G Varanasi; Kelly K Leong; Lisa M Dominia; Stephanie M Jue; Peter M Loomer; Grayson W Marshall
Journal:  J Oral Implantol       Date:  2012-08       Impact factor: 1.779

10.  Disturbance of inorganic phosphate metabolism in diabetes mellitus: temporary therapeutic intervention trials.

Authors:  Jørn Ditzel; Hans Henrik Lervang
Journal:  Diabetes Metab Syndr Obes       Date:  2009-10-08       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.